Semaglutide Side Effects: What's Normal, What's Not, and When to Call Your Doctor

Most people starting semaglutide experience some side effects. That's not a sign the medication isn't working — it's how GLP-1 drugs work. But there's a big difference between normal adjustment symptoms and signs that something is wrong.

Here's what the research actually shows, what patients commonly experience, and what warrants a call to your doctor.

The Most Common Side Effects

These are the side effects most people encounter, especially in the first few weeks:

• Nausea — affects 20–44% of patients on semaglutide. Usually worst when starting or increasing the dose.
• Vomiting — affects roughly 5–24% of patients. Tends to decrease significantly after the first month.
• Diarrhea — affects about 10–30% of patients, especially early on.
• Constipation — counterintuitively, some people experience the opposite effect. Both can occur.
• Stomach pain or discomfort — a general “unsettled” feeling in the abdomen is common, especially after eating.
• Reduced appetite — technically the mechanism, but can feel like a side effect when food becomes unappealing entirely.
• Fatigue — some patients feel tired, particularly in the first few weeks. This typically improves.

The pattern: most GI side effects peak in the first 4–12 weeks, then improve as your body adjusts. The standard dose escalation schedule is designed specifically to reduce these effects — going too fast on dose increases is one of the main reasons people have worse side effects.

Why These Side Effects Happen

Semaglutide slows gastric emptying — the rate at which your stomach moves food into your intestines. This is one of the main reasons it reduces appetite. But it also means your stomach is fuller for longer, which causes nausea in many people, especially right after eating.

As your body adjusts to the medication, gastric motility adapts and the nausea usually fades. Most patients describe their side effects as significantly better by months 2–3.

How to Manage Common Side Effects

A few things actually help:

• Eat smaller meals. Your stomach empties more slowly on semaglutide. Big meals make nausea worse.
• Avoid high-fat and spicy foods early on. These slow gastric emptying further and amplify GI symptoms.
• Don't lie down after eating. Give your stomach time to process before reclining.
• Stay hydrated. Vomiting and diarrhea can dehydrate you faster than you expect.
• Talk to your prescriber before increasing dose. The standard titration schedule exists for a reason. If you're having significant side effects at your current dose, staying there longer before going up is often better than pushing through.

Less Common but Important Side Effects

These affect a smaller percentage of patients but are worth knowing about:

• Headache — reported by about 9% of patients, usually mild and temporary.
• Dizziness — can occur, especially when starting the medication.
• Injection site reactions — redness, swelling, or mild pain where you inject. Usually minor and resolves quickly.
• Hair loss — some patients report temporary hair thinning. This appears to be related to rapid weight loss (a known phenomenon called telogen effluvium) rather than semaglutide itself. It typically resolves.
• Mood changes — some patients report changes in mood, anxiety, or depressive symptoms. The FDA added a warning about this; tell your doctor if you notice significant mood changes.

The Warning Signs: When to Call Your Doctor

These symptoms are less common, but they require immediate medical attention:

Pancreatitis. Severe, persistent abdominal pain — especially pain that radiates to your back — can signal pancreatitis. Stop taking semaglutide and go to the ER or call your doctor immediately. GLP-1 drugs have been associated with a small increased risk of pancreatitis, though causation is still debated.

Gallbladder problems. Rapid weight loss increases gallstone risk, and GLP-1 drugs may add to that. Symptoms include sudden pain in the upper right abdomen, nausea, and fever. This needs evaluation.

Severe allergic reaction. Difficulty breathing, severe rash, or swelling of the face and throat after injection. Call 911.

Vision changes. Recent research flagged a potential signal for eye-related events, particularly for patients with diabetes and pre-existing retinopathy. If you notice vision changes after starting semaglutide, have your eyes examined.

Kidney problems. Severe dehydration from vomiting can strain the kidneys. Signs include significantly reduced urination, swelling, or extreme fatigue. Get evaluated if you're having trouble keeping fluids down for more than 24 hours.

The Thyroid Question

You may have seen warnings about thyroid cancer on the Wegovy label. This is based on animal studies — rats and mice given semaglutide developed thyroid C-cell tumors. This has not been observed in humans in clinical trials or post-market surveillance.

The FDA still requires a black-box warning because the animal data can't be fully dismissed. If you have a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, semaglutide is contraindicated. For everyone else, current evidence doesn't suggest this is a meaningful human risk — but it's worth discussing with your doctor.

Most People Complete Treatment

In major clinical trials like STEP 1, about 7% of participants discontinued semaglutide due to side effects. That means roughly 93% completed the treatment course despite experiencing the side effects listed above.

The side effects are real. For most people, they're manageable — especially with the dose titration strategy and the practical tips above. For a small percentage, they're significant enough to stop.

If you're struggling with side effects, don't quit without talking to your prescriber first. In many cases, staying at the current dose longer, adjusting your eating patterns, or adding supportive medication makes a meaningful difference.

This article is for informational purposes only. Always consult your healthcare provider before starting, stopping, or changing any medication. Last updated: March 2026.